Published in J Gastrointest Surg on July 28, 2012
Damage Control Surgery in the Treatment of Complicated Diverticulitis (DACSCOD) | NCT03337984
Systematic review and meta-analysis of the open abdomen and temporary abdominal closure techniques in non-trauma patients. World J Surg (2015) 1.13
The role of the open abdomen procedure in managing severe abdominal sepsis: WSES position paper. World J Emerg Surg (2015) 1.07
WSES Guidelines for the management of acute left sided colonic diverticulitis in the emergency setting. World J Emerg Surg (2016) 0.99
Abdominal damage control surgery and reconstruction: world society of emergency surgery position paper. World J Emerg Surg (2013) 0.96
Position paper: management of perforated sigmoid diverticulitis. World J Emerg Surg (2013) 0.94
A proposal for a CT driven classification of left colon acute diverticulitis. World J Emerg Surg (2015) 0.90
Incisional hernia rate after open abdomen treatment with negative pressure and delayed primary fascia closure. Hernia (2013) 0.89
Current concept of abdominal sepsis: WSES position paper. World J Emerg Surg (2014) 0.85
Outcome after surgery for acute right-sided colonic ischemia without feasible vascular intervention: a single center experience of 58 patients over 6 years. BMC Surg (2015) 0.83
Outcome of negative-pressure wound therapy for open abdomen treatment after nontraumatic lower gastrointestinal surgery: analysis of factors affecting delayed fascial closure in 101 patients. World J Surg (2014) 0.79
Role of damage control surgery in the treatment of Hinchey III and IV sigmoid diverticulitis: a tailored strategy. Medicine (Baltimore) (2014) 0.79
Abdominal wall integrity after open abdomen: long-term results of vacuum-assisted wound closure and mesh-mediated fascial traction (VAWCM). Hernia (2016) 0.76
Intensive care and health outcomes of open abdominal treatment: long-term results of vacuum-assisted wound closure and mesh-mediated fascial traction (VAWCM). Langenbecks Arch Surg (2017) 0.76
The role of open abdomen in non-trauma patient: WSES Consensus Paper. World J Emerg Surg (2017) 0.75
Damage control strategy for the treatment of perforated diverticulitis with generalized peritonitis. Tech Coloproctol (2016) 0.75
Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res (2009) 2.75
Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation (2009) 2.28
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res (2006) 2.26
Biliary reconstruction using a side-to-side choledochocholedochostomy with or without T-tube in deceased donor liver transplantation: a prospective randomized trial. Ann Surg (2009) 2.19
Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept. Transpl Int (2010) 1.99
Up-regulation of neutrophil gelatinase-associated lipocalin in colorectal cancer predicts poor patient survival. World J Surg (2014) 1.98
The faster the better: anastomosis time influences patient survival after deceased donor kidney transplantation. Transpl Int (2015) 1.95
Hybrid video-assisted thoracic surgery-robotic minimally invasive right upper lobe sleeve lobectomy. Ann Thorac Surg (2011) 1.80
Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet (2004) 1.80
Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation. Transpl Int (2009) 1.77
Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg (2008) 1.74
Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias. Dis Markers (2005) 1.73
Immunohistochemical detection of hypoxia-inducible factor-1alpha in human renal allograft biopsies. J Am Soc Nephrol (2006) 1.61
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Nighttime procedures are not associated with adverse outcomes in kidney transplantation. Transpl Int (2013) 1.49
Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome. Liver Transpl (2008) 1.47
Enteroscopic biopsies in the management of pancreas transplants: a proof of concept study for a novel monitoring tool. Transplantation (2012) 1.40
Preparing for prospective clinical trials: a national initiative of an excellence registry for consecutive pancreatic cancer resections. World J Surg (2014) 1.39
Long-term results and complications following adjustable gastric banding. Obes Surg (2010) 1.32
Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Hum Pathol (2009) 1.31
Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma. Int J Cancer (2011) 1.28
Age and immune response in organ transplantation. Transplantation (2005) 1.23
DNA methylation in colorectal cancer--impact on screening and therapy monitoring modalities? Dis Markers (2007) 1.17
Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma. Clin Cancer Res (2005) 1.11
Management of esophageal perforations. Surg Endosc (2010) 1.10
High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function. Transpl Immunol (2008) 1.10
Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation (2004) 1.07
Results and complications after Swedish adjustable gastric banding-10 years experience. Obes Surg (2009) 1.07
Symptomatic lymphoceles after kidney transplantation - multivariate analysis of risk factors and outcome after laparoscopic fenestration. Clin Transplant (2009) 1.06
Extended surgical resection for xanthogranulomatous cholecystitis mimicking advanced gallbladder carcinoma: A case report and review of literature. World J Gastroenterol (2006) 1.05
Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation (2002) 1.05
Driving reaction time before and after primary fusion of the lumbar spine. Spine (Phila Pa 1976) (2010) 1.02
SFRP2 methylation in fecal DNA--a marker for colorectal polyps. Int J Colorectal Dis (2007) 1.02
DaVinci robotic-assisted laparoscopic bariatric surgery: is it justified in a routine setting? Obes Surg (2003) 1.00
IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival. J Immunol (2011) 1.00
Adjustable gastric and esophagogastric banding: a randomized clinical trial. Obes Surg (2002) 0.99
Acute-on-chronic liver failure: excellent outcomes after liver transplantation but high mortality on the wait list. Liver Transpl (2013) 0.98
Recipient and donor body mass index as important risk factors for delayed kidney graft function. Transplantation (2012) 0.98
Endothelial progenitor cells: current issues on characterization and challenging clinical applications. Stem Cell Rev (2012) 0.97
Mouse hind limb transplantation: a new composite tissue allotransplantation model using nonsuture supermicrosurgery. Transplantation (2010) 0.96
Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial. Transplantation (2010) 0.96
Graft versus host disease after liver transplantation - a single center experience and review of literature. Transpl Int (2008) 0.96
Functional outcome after hand and forearm transplantation: what can be achieved? Hand Clin (2011) 0.95
KIR/HLA ligand incompatibility in kidney transplantation. Transplantation (2007) 0.94
Quantification of circulating endothelial and progenitor cells: comparison of quantitative PCR and four-channel flow cytometry. BMC Res Notes (2008) 0.94
Dickkopf-3 as a new potential marker for neoangiogenesis in colorectal cancer: expression in cancer tissue and adjacent non-cancerous tissue. Dis Markers (2008) 0.92
Long-term outcome of liver resection and transplantation for Caroli disease and syndrome. Ann Surg (2008) 0.91
Preoperative evaluation of living kidney donors using multirow detector computed tomography: comparison with digital subtraction angiography and intraoperative findings. Transpl Int (2005) 0.91
Single-center experience with third and fourth kidney transplants. Transpl Int (2011) 0.90
Robotic-assisted minimally invasive vs. thoracoscopic lung lobectomy: comparison of perioperative results in a learning curve setting. Langenbecks Arch Surg (2013) 0.90
Laparoscopic Swedish adjustable gastric banding: 6-year follow-up and comparison to other laparoscopic bariatric procedures. Obes Surg (2003) 0.90
Chances and limitations of non-invasive tests in the assessment of liver fibrosis in liver transplant patients. Clin Transplant (2010) 0.90
Results and complications after laparoscopic sleeve gastrectomy. Surg Today (2014) 0.90
Early diagnosis of primary nonfunction and indication for reoperation after liver transplantation. Liver Transpl (2010) 0.90
Single-incision laparoscopic sleeve gastrectomy. Am Surg (2013) 0.90
Modified ELISPOT technique--highly significant inverse correlation of post-Tx donor-reactive IFNgamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients. Transpl Immunol (2006) 0.89
Role of heme oxygenase-1 in transplantation. Transpl Int (2010) 0.89
Prognostic significance of the DNA-index in liver transplantation for hepatocellular carcinoma in cirrhosis. Ann Surg (2009) 0.89
Practical recommendations for the early use of m-TOR inhibitors (sirolimus) in renal transplantation. Transpl Int (2009) 0.88
Prevalent esophageal body motility disorders underlie aggravation of GERD symptoms in morbidly obese patients following adjustable gastric banding. Arch Surg (2006) 0.88
Alterations of the immune response with increasing recipient age are associated with reduced long-term organ graft function of rat kidney allografts. Transplantation (2003) 0.88
Present status and future perspectives of intestinal transplantation. Transpl Int (2008) 0.88
Open abdomen treatment with dynamic sutures and topical negative pressure resulting in a high primary fascia closure rate. World J Surg (2012) 0.88
Laparoscopic resection of a giant liver hemangioma. J Laparoendosc Adv Surg Tech A (2005) 0.88
Weight loss increases soluble leptin receptor levels and the soluble receptor bound fraction of leptin. Obes Res (2002) 0.87
Early viral load and recipient interleukin-28B rs12979860 genotype are predictors of the progression of hepatitis C after liver transplantation. Liver Transpl (2012) 0.87
Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis. Clin Gastroenterol Hepatol (2013) 0.86
Robotic-assisted thoracoscopic surgery (RATS) for benign and malignant esophageal tumors. Ann Thorac Surg (2005) 0.86
World experience after more than a decade of clinical hand transplantation: update on the Innsbruck program. Hand Clin (2011) 0.86
A multicentre, randomized clinical trial comparing the Veriset™ haemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery. HPB (Oxford) (2012) 0.85
Successful management of six pregnancies resulting in live births after simultaneous pancreas kidney transplantation: a single-center experience. Transpl Int (2014) 0.85
Induction of carbon monoxide in donor animals prior to organ procurement reduces graft immunogenicity and inhibits chronic allograft dysfunction. Transplantation (2006) 0.85
Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantation. Transpl Int (2012) 0.85
Enterolithiasis-associated ileus in Crohn's disease. World J Gastroenterol (2012) 0.85
How to define initial poor graft function after liver transplantation? - a new functional definition by the LiMAx test. Transpl Int (2010) 0.85
Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study. Strahlenther Onkol (2011) 0.85
Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results. Liver Transpl (2009) 0.85
Bovine pericardium for portal vein reconstruction in abdominal surgery: a surgical guide and first experiences in a single center. Dig Surg (2015) 0.85
Aspergillus spondylodiscitis after multivisceral transplantation. Ann Transplant (2009) 0.84
Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation. Transpl Int (2009) 0.84
Prevention of lethal murine pancreas ischemia reperfusion injury is specific for tetrahydrobiopterin. Transpl Int (2012) 0.84
The role of lipocalin-2 in liver regeneration. Liver Int (2014) 0.84
Management of biliary complications following living donor liver transplantation--a single center experience. Langenbecks Arch Surg (2009) 0.84
Novel markers in zero-hour kidney biopsies indicate graft quality and clinical outcome. Transplantation (2010) 0.84
Safety of mycophenolate mofetil monotherapy in patients after liver transplantation. Ann Transplant (2009) 0.83
Postoperative vasopressin and copeptin levels in noncardiac surgery patients: a prospective controlled trial. Shock (2009) 0.83
Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. J Am Soc Nephrol (2002) 0.83
Impact of brain death on ischemia/reperfusion injury in liver transplantation. Curr Opin Organ Transplant (2014) 0.83
Combined pancreas-kidney transplantation for patients with end-stage nephropathy caused by type-2 diabetes mellitus. Transplantation (2013) 0.82
Risk factors of metabolic disorders after liver transplantation: an analysis of data from fasted patients. Transplantation (2015) 0.82
Antineoplastic activity of 2-methoxyestradiol in human pancreatic and gastric cancer cells with different multidrug-resistant phenotypes. J Gastroenterol Hepatol (2007) 0.82
The utility of extended criteria donor organs in severely ill liver transplant recipients. Transplantation (2008) 0.82
Lipocalin-2 as mediator of chemokine expression and granulocyte infiltration during ischemia and reperfusion. Transpl Int (2013) 0.81
Evolution of pancreas transplantation: long-term results and perspectives from a high-volume center. Ann Surg (2012) 0.81
Results and complications after laparoscopic adjustable gastric banding in super-obese patients, using the Swedish band. Obes Surg (2004) 0.81